Use of Psychotropic Medication in the General Population of France, Germany, Italy, and the United Kingdom
The DOI matches its Crossref record.
Abstract
BACKGROUND: The use of psychotropic medications and its association with sleep and psychiatric and physical illnesses were studied in the general population. METHOD: A cross-sectional telephone survey was carried out using the Sleep-EVAL knowledge-base system. A representative sample of the noninstitutionalized general populations of France, Germany, Italy, and the United Kingdom, aged 15 years or over, was interviewed (N = 18,679; participation rate: 78.8%; target population: 204,605,391 inhabitants). Questions were asked about psychotropic medication intake (name of medication, indication, dosage, duration of intake, prescriber), sociodemographics, physical illnesses, and DSM-IV mental disorders. RESULTS: At the time of the interview, 6.4% of the subjects took a psychotropic medication. Anxiolytics were reported by 4.3% of the sample, hypnotics by 1.5%, antidepressants by 1.0%, and neuroleptics and other psychotropics by less than 1.0%. Hypnotics and anxiolytics were mostly used as a sleep disorder treatment. Antidepressants were taken appropriately for a depressive illness in only 44.1% of cases. Low doses of hypnotics and anxiolytics were found in about 10% of cases and low doses of antidepressants in 31.7% of cases. Subjects with a psychiatric disorder received a psychotropic treatment only infrequently (between 10% to 40.4%, depending on the disorder). All psychiatric disorders, including mood disorders, were treated mainly with an anxiolytic. A concomitant physical illness increased the likelihood of using a psychotropic treatment and was a strong predictor of adequate psychotropic dosage. CONCLUSION: Psychiatric pathology and sleep disorders remained mostly untreated or inadequately managed in the general population. Depression is underdiagnosed by the physicians and is treated with antidepressant in only 7% of cases. By contrast, anxiolytics are extensively prescribed, especially in France and Italy. The co-occurrence of organic and psychiatry disorders increases the frequency of medical consultations and the likelihood of being given a prescription for the mental disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“adding CBT was of limited value in one trial, 22 but facilitated discontinuation in other trials. 23,24”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [22]
In the citing paper
“a brief GP intervention based on gradual dose reduction, resulting in 3-12 months discontinuation rates of 51% and 45% respectively. 14,22”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [22]
In the citing paper
“The results of studies on such strategies have been inconsistent.”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [22]
Citations
Cites
Still being checked.
Cited by
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Self-citationEvolution 1998-2002 of the antidepressant consumption in France, Germany and the United KingdomPreprint
Grandfils, N., & Sermet, C. (2009) · RePEc: Research Papers in Economics · Cited by 399
The ESEMeD/MHEDEA 2000 investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00331.x · Cited by 314
Residual Effects of Hypnotics: Epidemiology and Clinical Implications
Vermeeren, A. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00003 · Cited by 277
Griffiths, R. R., & Johnson, M. W. (2005) · PubMed · Cited by 260
Psychotropic Medications and the Risk of Fracture: A Meta-Analysis
Takkouche, B., Montes-Mart??nez, A., Gill, S. S., & Etminan, M. (2007) · Drug Safety · doi:10.2165/00002018-200730020-00006 · Cited by 204
Incidence and Recurrence of Late-Life Depression
Luijendijk, H. J., van den Berg, J. F., Dekker, M. J. H. J., van Tuijl, H. R., Otte, W., Smit, F., Hofman, A., Stricker, B. H. C., & Tiemeier, H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.12.1394 · Cited by 193
Antipsychotic Drug Use and Risk of Pneumonia in Elderly People
Knol, W., Van Marum, R. J., Jansen, P. A. F., Souverein, P. C., Schobben, A. F. A. M., & Egberts, A. C. G. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01625.x · Cited by 193
Boscarino, J. A., Adams, R. E., & Figley, C. R. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2004.05.001 · Cited by 185
Patterns and correlates of benzodiazepine use in the French general population
Lagnaoui, R., Depont, F., Fourrier, A., Abouelfath, A., B�gaud, B., Verdoux, H., & Moore, N. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0808-2 · Cited by 160
Usage of benzodiazepines: A review
Donoghue, J., & Lader, M. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651500903447810 · Cited by 156
Self-citationUnderstanding the prescription of antidepressants: a Qualitative study among French GPs
Mercier, A., Aubin-Auger, I., Lebeau, J., Royen, P. V., & Peremans, L. (2011) · BMC Family Practice · doi:10.1186/1471-2296-12-99 · Cited by 171
Morselli, P. L., & Elgie, R. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00037.x · Cited by 150
Lewer, D., O'Reilly, C., Mojtabai, R., & Evans-Lacko, S. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156786 · Cited by 150
Clinical factors influencing the prescription of antidepressants and benzodiazepines:
Demyttenaere, K., Bonnewyn, A., Bruffaerts, R., de Girolamo, G., Gasquet, I., Kovess–Masféty, V., Haro, J. M., & Alonso, J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.011 · Cited by 157
Huerta, C., Abbing‐Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P. C., et al. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3825 · Cited by 130
Vicens, C., Bejarano, F., Sempere, E., Mateu, C., Fiol, F., Socias, I., Aragonès, E., Palop, V., Beltran, J. L., Piñol, J. L., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.134650 · Cited by 122
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants
Ghaemi, S. N., Hsu, D. J., Thase, M. E., Wisniewski, S. R., Nierenberg, A. A., Miyahara, S., & Sachs, G. (2006) · Psychiatric Services · doi:10.1176/appi.ps.57.5.660 · Cited by 121
Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
Pollmann, A. S., Murphy, A. L., Bergman, J. C., & Gardner, D. M. (2015) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-015-0019-8 · Cited by 114
Ansseau, M., Fischler, B., Dierick, M., Albert, A., Leyman, S., & Mignon, A. (2008) · Depression and Anxiety · doi:10.1002/da.20306 · Cited by 114
Morselli, P., Elgie, R., & Cesana, B. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00160.x · Cited by 114
Cunningham, C. M., Hanley, G. E., & Morgan, S. (2010) · Health Policy · doi:10.1016/j.healthpol.2010.03.008 · Cited by 121
Long-term use of benzodiazepines in chronic insomnia: a European perspective
Soyka, M., Wild, I., Caulet, B., Leontiou, C., Lugoboni, F., & Hajak, G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1212028 · Cited by 121
Kovess–Masféty, V., Saragoussi, D., Sevilla‐Dedieu, C., Gilbert, F., Suchocka, A., Arveiller, N., Gasquet, I., Younès, N., & Hardy-Baylé, M. C. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-188 · Cited by 136
Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
Lundberg, J., Odano, I., Olsson, H., Halldin, C., & Farde, L. (2005) · PubMed · Cited by 109
Gasquet, I., Nègre‐Pagès, L., Fourrier, A., Nachbaur, G., El-Hasnaoui, A., Kovess–Masféty, V., & Lépine, J. (2005) · L Encéphale · doi:10.1016/s0013-7006(05)82386-3 · Cited by 101
Boyd, A., Van de Velde, S., Pivette, M., ten Have, M., Florescu, S., O’Neill, S., Caldas-de-Almeida, J.-M., Vilagut, G., Haro, J. M., Alonso, J., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.05.001 · Cited by 90
Elgie, R., & Morselli, P. L. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00339.x · Cited by 88
Treatment of major depressive disorder in the Finnish general population
Hämäläinen, J., Isometsä, E., Sihvo, S., Kiviruusu, O., Pirkola, S., & Lönnqvist, J. (2009) · Depression and Anxiety · doi:10.1002/da.20524 · Cited by 86
Antidepressants and age: A new form of evidence for U-shaped well-being through life
Blanchflower, D. G., & Oswald, A. J. (2016) · Journal of Economic Behavior & Organization · doi:10.1016/j.jebo.2016.04.010 · Cited by 107
A Review on the Effects of Aromatherapy for Patients with Depressive Symptoms
Yim, V. W. C., Ng, A. K. Y., Tsang, H. W. H., & Leung, A. Y. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0333 · Cited by 94
Smith, A. J., & Tett, S. E. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-321 · Cited by 82
Mystakidou, K., Tsilika, E., Parpa, E., Pathiaki, M., Patiraki, E. I., Galanos, A., & Vlahos, L. J. (2007) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2007.02.002 · Cited by 95
do Prado, M. A. M. B., Francisco, P. M. S. B., & Barros, M. B. D. A. (2017) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-49742017000400007 · Cited by 78
Ansseau, M., Fischler, B., Dierick, M., Mignon, A., & Leyman, S. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.09.035 · Cited by 77
Quality of life in a cohort of high-dose benzodiazepine dependent patients
Lugoboni, F., Mirijello, A., Faccini, M., Casari, R., Cossari, A., Musi, G., Bissoli, G. C., Quaglio, G., & Addolorato, G. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.06.020 · Cited by 79
Modificações nos padrões de consumo de psicofármacos em localidade do Sul do Brasil
Rodrigues, M. A., Facchini, L. A., & de Lima, M. S. (2006) · Revista de Saúde Pública · doi:10.1590/s0034-89102006000100017 · Cited by 75
Sundbom, L. T., Bingefors, K., Hedborg, K., & Isacson, D. G. L. (2017) · BJPsych Bulletin · doi:10.1192/pb.bp.116.054270 · Cited by 93
Sleep Disturbance in Supportive Care of Cancer: A Review
Kvale, E. A., & Shuster, J. L. (2006) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9.437 · Cited by 75
Bongué, B., Laroche, M., Gutton, S., Colvez, A., Gueguen, R., Moulin, J. J., & Merle, L. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1077-5 · Cited by 76
Torres-Bondia, F., de Batlle, J., Galván, L., Buti, M., Barbé, F., & Piñol-Ripoll, G. (2020) · BMC Public Health · doi:10.1186/s12889-020-08984-z · Cited by 69
Mura, T., Proust‐Lima, C., Akbaraly, T. N., Amieva, H., Tzourio, C., Chevassus, H., Picot, M., Jacqmin‐Gadda, H., & Berr, C. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.004 · Cited by 82
Sleep, hypnotics and chronic obstructive pulmonary disease
Stege, G., Vos, P. J. E., van den Elshout, F. J. J., Dekhuijzen, P. N. R., van de Ven, M. J. T., & Heijdra, Y. F. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.12.026 · Cited by 69
Brunoni, A. R., Nunes, M. A., de Figueiredo, R. C., Barreto, S. M., da Fonseca, M. D. J. M., Lotufo, P. A., & Benseñor, I. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.054 · Cited by 74
The Prevalence and Incidence of Insomnia in Korea during 2005 to 2013
Chung, S., Cho, S. W., Jo, M., Youn, S., Lee, J., & Sim, C. S. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0218 · Cited by 69
Acquaviva, É., Legleye, S., Auleley, G.-R., Deligne, J., Carel, D., & Falissard, B. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-72 · Cited by 79
Drug related falls: a study in the French pharmacovigilance database
Souchet, E., Lapeyre‐Mestre, M., & Montastruc, J. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1038 · Cited by 59
Lasserre, A., Younès, N., Blanchon, T., Cantegreil-Kallen, I., Passerieux, C., Thomas, G., Chan-Chee, C., & Hanslik, T. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483922 · Cited by 60
Bobes, J., Rubio, G., Terán, A., Cervera, G., López-Gómez, V., Vilardaga, I., & Pérez, M. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2010.12.004 · Cited by 57
Kjosavik, S. R., Ruths, S., & Hunskaar, S. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1756 · Cited by 56
Benzodiazepine Use among Older Adults with Chronic Obstructive Pulmonary Disease
Vozoris, N. T., Fischer, H. D., Wang, X., Anderson, G., Bell, C. M., Gershon, A. S., Stephenson, A. L., Gill, S. S., & Rochon, P. A. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0056-1 · Cited by 55
Norton, J. L., de Roquefeuil, G., David, M., Boulenger, J.-P., Ritchie, K. A., & MANN, A. H. (2009) · L Encéphale · doi:10.1016/j.encep.2008.06.018 · Cited by 70
The effect of mirtazapine in patients with chronic pain and concomitant depression
Freynhagen, R., Muth‐Selbach, U., Lipfert, P., Stevens, M. F., Zacharowski, K., Tölle, T., & von Giesen, H. ‐. (2005) · Current Medical Research and Opinion · doi:10.1185/030079906x80486 · Cited by 58
Concomitant use of analgesics and psychotropics in home‐dwelling elderly people‐Kuopio 75 + study
Hartikainen, S., Mäntyselkä, P., Louhivuori‐Laako, K., Enlund, H., & Sulkava, R. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02417.x · Cited by 53
Bénard‐Laribière, A., Noïze, P., Pambrun, É., Bazin, F., Verdoux, H., Tournier, M., Bégaud, B., & Pariente, A. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2044-y · Cited by 66
Wang, L., Chen, Y., Chen, C.-K., Chou, W., & Chou, M. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201300066 · Cited by 51
Antidepressant use and breast cancer risk
Chien, C., Li, C. I., Heckbert, S. R., Malone, K. E., Boudreau, D. M., & Daling, J. R. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9056-0 · Cited by 49
Quaglio, G., Pattaro, C., Gerra, G., Mathewson, S., Verbanck, P., Des Jarlais, D. C., & Lugoboni, F. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.008 · Cited by 48
Psychotropics use in the Spanish elderly: predictors and evolution between years 1993 and 2003
Carrasco‐Garrido, P., Jiménez‐García, R., Astasio‐Arbiza, P., Ortega‐Molina, P., & de Miguel, A. G. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1344 · Cited by 48
Uso e fontes de obtenção de psicotrópicos em adultos e idosos brasileiros
Rodrigues, P. S., Francisco, P. M. S. B., Fontanella, A. T., Borges, R. B., & Costa, K. S. (2020) · Ciência & Saúde Coletiva · doi:10.1590/1413-812320202511.35962018 · Cited by 47
Bocca, M., Marie, S., Lelong‐Boulouard, V., Bertran, F., Couque, C., Desfemmes, T., Berthelon, C., Amato, J.-N., Moessinger, M., Paillet‐Loilier, M., et al. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2075-5 · Cited by 50
Epidemiology of Psychotropic Drug Use in Rio de Janeiro, Brazil: Gaps in Mental Illness Treatments
Quintana, M. I., Andreoli, S. B., Moreira, F. G., Ribeiro, W. S., Feijo, M. M., Bressan, R. A., Coutinho, E. S. F., & Mari, J. D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062270 · Cited by 49
Vozoris, N. T., & Leung, R. S. T. (2011) · SLEEP · doi:10.5665/sleep.1116 · Cited by 46
Evolución del uso de medicamentos ansiolíticos e hipnóticos en España durante el período 2000-2011
Vicente Sánchez, M. P., Macías Saint-Gerons, D., Fuente Honrubia, C. D. L., González Bermejo, D., Montero Corominas, D., & Catalá-López, F. (2013) · Revista Española de Salud Pública · doi:10.4321/s1135-57272013000300004 · Cited by 45
Chien, I., Bih, S., Chou, Y., Lin, C.-H., Lee, W.-G., & Chou, P. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.4.554 · Cited by 45
Vicens, C., Sempere, E., Bejarano‐Romero, F., Socias, I. M., Mateu, C., Fiol, F., Palop, V., Mengual, M., Folch, S., Calatayud, G. L., et al. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x683485 · Cited by 58
The Use of Benzodiazepine Receptor Agonists and the Risk of Hospitalization for Pneumonia
Chen, T., Winkelman, J. W., Mao, W., Liu, C., Hsu, C., & Wu, C. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.07.030 · Cited by 48
Análisis de los costes de la enfermedad de Alzheimer en función del deterioro cognitivo y funcional
Pousa, S. L., Garre‐Olmo, J., Estrada, A. T., Hernández, F., Expósito, I., Lozano-Gallego, M., Hernández-Ferràndiz, M., Gelada-Batlle, E., Nierga, I. P., & Franch, J. V. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)74381-x · Cited by 59
Revet, A., Montastruc, F., Raynaud, J., Baricault, B., Montastruc, J., & Lapeyre‐Mestre, M. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000891 · Cited by 47
Kölch, M. G., Prestel, A., Singer, H., Keller, F., Fegert, J. M., Schlack, R., Hoelling, H., & Knopf, H. C. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0018 · Cited by 47
Puustinen, J., Nurminen, J., Kukola, M., Vahlberg, T. J., Laine, K., & Kivelä, S. (2007) · Drugs & Aging · doi:10.2165/00002512-200724120-00007 · Cited by 56
Norton, J., De Roquefeuil, G., Boulenger, J.-P., Ritchie, K., Mann, A., & Tylee, A. (2007) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.02.005 · Cited by 38
Determinants of Quality of Life in High-Dose Benzodiazepine Misusers
Tamburin, S., Federico, A., Faccini, M., Casari, R., Morbioli, L., Sartore, V., Mirijello, A., Addolorato, G., & Lugoboni, F. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14010038 · Cited by 41
Faccini, M., Leone, R., Opri, S., Casari, R., Resentera, C., Morbioli, L., Conforti, A., & Lugoboni, F. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116647505 · Cited by 38
Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort
Boeuf-Cazou, O., Bongué, B., Ansiau, D., Marquié, J.-C., & Lapeyre‐Mestre, M. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1047-y · Cited by 53
Balestrieri, M., Marcon, G., Samani, F., Marini, M., Sessa, E., Gelatti, U., & Donato, F. (2005) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-005-0899-9 · Cited by 42
Windfuhr, K., While, D., Kapur, N., Ashcroft, D. M., Kontopantelis, E., Carr, M. J., Shaw, J., Appleby, L., & Webb, R. T. (2016) · Psychological Medicine · doi:10.1017/s0033291716001823 · Cited by 34
“It is therefore important for GPs to be aware of the elevated risk associated with multiple presentations that may not be considered high frequency.”
BackgroundInfluentialHenriksson, S., Asplund, R., Boëthius, G., Hällström, T., & Isacsson, G. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2006.04.003 · Cited by 32
Meskali, M., Berthelon, C., Marie, S., Denise, P., & Bocca, M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1677-2 · Cited by 32
Parslow, R., & Jorm, A. F. (2003) · Journal of Affective Disorders · doi:10.1016/j.jad.2003.09.013 · Cited by 32
Psychotropic Medication Use in Children and Adolescents: A Study from France
Sevilla‐Dedieu, C., & Kovess–Masféty, V. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0091 · Cited by 34
Psychotropic Drug Use in São Paulo, Brazil – An Epidemiological Survey
Quintana, M. I., Andreoli, S. B., Peluffo, M. P., Ribeiro, W. S., Feijo, M. M., Bressan, R. A., Coutinho, E. S. F., & Mari, J. D. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135059 · Cited by 37
Bocquier, A., Bezzou, K., Nauleau, S., & Verger, P. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00587.x · Cited by 31
Objective: remission of depression in primary care
Ansseau, M., Demyttenaere, K., Heyrman, J., Migeotte, A., Leyman, S., & Mignon, A. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.10.003 · Cited by 37
Treatment of anxiety disorders in the Finnish general population
Sihvo, S., Hämäläinen, J., Kiviruusu, O. H., Pirkola, S. P., & Isometsä, E. T. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.05.009 · Cited by 31
Prevalence of Psychotropic Use in a South Australian Population
Goldney, R. D., & Bain, M. A. (2006) · Australasian Psychiatry · doi:10.1080/j.1440-1665.2006.02308.x · Cited by 32
Miyata, A., Iwamoto, K., Kawano, N., Kohmura, K., Yamamoto, M., Aleksić, B., Ebe, K., Noda, A., Noda, Y., Iritani, S., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3843-4 · Cited by 31
Cuevas, C. D. L., Ramallo‐Fariña, Y., & Sanz, E. J. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.02.013 · Cited by 30
The Lorhandicap Group, Peretti‐Watel, P., Legleye, S., Baumann, M., Choquet, M., Falissard, B., & Chau, N. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-008-0487-x · Cited by 28
Lombardi, N., Bettiol, A., Crescioli, G., Ravaldi, C., Bonaiuti, R., Venegoni, M., Vighi, G. D., Mugelli, A., Mannaioni, G., Vannacci, A., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02339-7 · Cited by 28
Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort
Colman, I., Wadsworth, M. E. J., Croudace, T. J., & Jones, P. B. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.105.017434 · Cited by 28
A Comparison of Benzodiazepine and Related Drug Use in Nova Scotia and Australia
Smith, A. J., SKETRIS, I. S., Cooke, C., Gardner, D. M., Kisely, S. R., & Tett, S. E. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805300809 · Cited by 28
Psychotropic prescribing in Catalonia: results from an epidemiological study
Rubio-Valera, M., Fernández, A., Luciano, J. V., Hughes, C. M., Pinto‐Meza, A., Moreno‐Küstner, B., Palao, D. J., Haro, J. M., & Serrano‐Blanco, A. (2011) · Family Practice · doi:10.1093/fampra/cmr078 · Cited by 25
Harris, M., Burgess, P. M., Pirkis, J., Siskind, D. J., Slade, T. N., & Whiteford, H. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.531459 · Cited by 26
Grimaldi‐Bensouda, L., Engel, P., Massol, J., Guillemot, D., Avouac, B. P., Duru, G., Lert, F., Magnier, A., Rossignol, M., Rouillon, F., et al. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001498 · Cited by 30
Grolleau, A., Cougnard‐Grégoire, A., Bégaud, B., & Verdoux, H. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01109.x · Cited by 24
Grolleau, A., Cougnard‐Grégoire, A., Bégaud, B., & Verdoux, H. (2008) · L Encéphale · doi:10.1016/j.encep.2007.07.011 · Cited by 24
Kripke, D. F. (2006) · Springer eBooks · doi:10.1007/0-387-27682-3_15 · Cited by 24
People with insomnia: experiences with sedative hypnotics and risk perception
Cheung, J. M. Y., Bartlett, D. J., Armour, C. L., Ellis, J. G., & Saini, B. (2015) · Health Expectations · doi:10.1111/hex.12388 · Cited by 31
Depression, Burnout and Effort-Reward Imbalance among Psychiatrists
Braun, M., Schönfeldt‐Lecuona, C., Freudenmann, R. W., Mehta, T. D., Hay, B. J., Kächele, H., & Beschoner, P. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000319531 · Cited by 22
Metadata
- Authors
- Ohayon, M. M., & Lader, M. H.
- Affiliations
- Stanford Medicine (US)
- ORCID
- Ohayon, Maurice M.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-09-15
- Volume
- 63
- Issue
- 9
- Pages
- 817-825
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2137401427
- Cited by
- 271
- References
- 0
- Citations by year
- 2025: 3 · 2024: 10 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 33 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 11 · 2015: 12 · 2014: 11 · 2013: 11 · 2012: 11
- FWCI
- 15.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- psychotropic drug use, anxiolytics, hypnotics, antidepressants, antipsychotic drugs, sleep disorders, underdiagnosis of depression, mental illness, prescribing patterns, general population
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Mental Disorders, Cross-Cultural Comparison, Drug Utilization, Expert Systems, Female, France, Germany, United Kingdom, Humans, Hypnotics and Sedatives, Italy, Male, Middle Aged, Practice Patterns, Physicians', Psychotropic Drugs, Sleep Wake Disorders, Anti-Anxiety Agents, Comorbidity, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.